Cardiology
Conference Coverage
Primordial cardiovascular prevention draws closer
“LDL and blood pressure, which are modifiable, may be more powerful determinants of lifetime risk than polygenic predisposition.” – Dr. Brian A....
Med Tech Report
The power and promise of person-generated health data (Part II)
While PGHD has the potential to help people, it also presents new challenges.
From the Journals
Wuhan data link COVID-19 with myocardial damage
Feature
COVID-19 shifts telehealth to the center of cardiology
A series of recent mandates aimed at addressing barriers to telehealth ‘have come in a time of desperation,’ one New York–based cardiologist says...
Commentary
CVH in pregnant women: Ample room for improvement
A recent study on cardiovascular health in pregnant women is an important step toward the development of pregnancy-specific guidelines and...
Conference Coverage
Low fitness level linked to higher risk of heart failure in diabetes
PHOENIX –Therapies targeting large and sustained improvements in fitness and weight loss may modify the risk of heart failure in patients with...
Conference Coverage
Dramatic rise in hypertension-related deaths in the United States
The ‘alarming’ increase in hypertension-related deaths between 2007 and 2017, was particularly prominent in the rural South.
Conference Coverage
AFib-related cardiovascular deaths on the rise
PHOENIX, ARIZ. – A more pronounced increase in mortality rate was observed among black and white men.
Conference Coverage
Cardiovascular risk varies between black ethnic subgroups
PHOENIX, ARIZ. – Smoking prevalence was highest in whites and African Americans, compared with African immigrants and Afro-Caribbeans.
Feature
COVID-19 will test medical supply stocks
“In the matter of a week or two...I think we’ll get a feel for whether or not we really have enough of the supplies that it takes,” said Dr....
Latest News
COVID-19: U.S. cardiology groups reaffirm continued use of RAAS-active drugs
Experts give ACE inhibitors and ARBs, cornerstones of cardiology therapy, a thumbs up despite a hypothetical adverse COVID-19 effect.